We are live on ! Find out more
SFSIG

San Francisco Sentry Investment Group Portfolio holdings

AUM $192M
1-Year Est. Return 276.26%
This Fund
S&P 500
This Quarter Est. Return
+27.98%
1 Year Est. Return
+276.26%
3 Year Est. Return
+441.01%
5 Year Est. Return
+660.73%
10 Year Est. Return
AUM
$188M
AUM Growth
+$30.4M
Cap. Flow
-$4.59M
Cap. Flow %
-2.44%
Top 10 Hldgs %
30.32%
Holding
940
New
56
Increased
176
Reduced
300
Closed
270

Sector Composition

Rank Sector Weight
1 Technology 16%
2 Healthcare 11.25%
3 Consumer Discretionary 10.42%
4 Communication Services 8.03%
5 Financials 7.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TEAM icon
351
Atlassian
TEAM
$39.1B
$42K 0.02%
232
-30
-11% -$4.98K
MCK icon
352
McKesson
MCK
$105B
$41K 0.02%
269
-28
-9% -$4.04K
RSP icon
353
Invesco S&P 500 Equal Weight ETF
RSP
$99.4B
$41K 0.02%
407
F icon
354
Ford
F
$55.7B
$40K 0.02%
6,500
-1,091
-14% -$6.04K
IEFA icon
355
iShares Core MSCI EAFE ETF
IEFA
$195B
$40K 0.02%
703
WST icon
356
West Pharmaceutical
WST
$24.7B
$40K 0.02%
175
CSX icon
357
CSX Corp
CSX
$92.5B
$39K 0.02%
1,641
-870
-35% -$19.2K
MS icon
358
Morgan Stanley
MS
$338B
$39K 0.02%
806
-182
-18% -$7.64K
BDX icon
359
Becton Dickinson
BDX
$49.4B
$38K 0.02%
162
-25
-13% -$6.03K
HDV
360
iShares Core High Dividend ETF
HDV
$15B
$38K 0.02%
2,350
KLAC icon
361
KLA
KLAC
$262B
$38K 0.02%
1,950
KXI icon
362
iShares Global Consumer Staples ETF
KXI
$1.06B
$38K 0.02%
730
VRSK icon
363
Verisk Analytics
VRSK
$23.6B
$37K 0.02%
216
-13
-6% -$2.05K
BMRN icon
364
BioMarin Pharmaceuticals
BMRN
$13.5B
$36K 0.02%
295
-2
-0.7% -$199
SPYD icon
365
State Street SPDR Portfolio S&P 500 High Dividend ETF
SPYD
$7.7B
$36K 0.02%
1,305
-5,849
-82% -$160K
BIIB icon
366
Biogen
BIIB
$30.1B
$35K 0.02%
133
-77
-37% -$23.1K
COP icon
367
ConocoPhillips
COP
$151B
$35K 0.02%
840
-352
-30% -$14.2K
GSEU icon
368
Goldman Sachs ActiveBeta Europe Equity ETF
GSEU
$126M
$35K 0.02%
1,280
LULU icon
369
lululemon athletica
LULU
$14.3B
$35K 0.02%
113
-4
-3% -$1.02K
OTIS icon
370
Otis Worldwide
OTIS
$27.8B
$35K 0.02%
+623
New +$32.3K
REGN icon
371
Regeneron Pharmaceuticals
REGN
$82.1B
$35K 0.02%
56
+46
+460% +$26.1K
SRPT icon
372
Sarepta Therapeutics
SRPT
$1.92B
$35K 0.02%
220
-47
-18% -$6.4K
GMAN
373
DELISTED
Goldman Sachs Manufacturing Revolution ETF
GMAN
$35K 0.02%
+610
New +$31.6K
ADPT icon
374
Adaptive Biotechnologies
ADPT
$4.04B
$33K 0.02%
692
+413
+148% +$15.1K
LRGF icon
375
iShares US Equity Factor ETF
LRGF
$3.7B
$33K 0.02%
1,050
-1,895
-64% -$56.3K

Similar funds

San Francisco Sentry Investment Group's Q2 2020 Portfolio in Review

As of Q2 2020, San Francisco Sentry Investment Group held 940 positions worth $188M, up 19% from $158M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

San Francisco Sentry Investment Group's Q2 2020 filing shows 56 new, 176 increased, 300 reduced and 270 closed positions. Its largest new stake was VanEck Rare Earth/Strategic Metals ETF: 22,420 shares worth $765K. The largest sale was State Street Utilities Select Sector SPDR ETF, an estimated $2.88M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • San Francisco Sentry Investment Group's largest Q2 2020 buy was VanEck Rare Earth/Strategic Metals ETF: 22,420 shares worth $765K.
  • San Francisco Sentry Investment Group added most to iShares 20+ Year Treasury Bond ETF in Q2 2020, an estimated $1.29M increase.
  • San Francisco Sentry Investment Group's biggest Q2 2020 reduction was State Street Utilities Select Sector SPDR ETF, cutting an estimated $2.88M.
  • San Francisco Sentry Investment Group fully exited Raytheon Company in Q2 2020, selling an estimated $328K.
  • San Francisco Sentry Investment Group's ten largest holdings make up 30% of its $188M portfolio in Q2 2020.
  • San Francisco Sentry Investment Group opened 56 new positions and closed 270 in Q2 2020.
  • San Francisco Sentry Investment Group's portfolio value rose 19% quarter-over-quarter to $188M.

Based on San Francisco Sentry Investment Group's 13F filing for Q2 2020, filed 17 Jul 2020.